Literature DB >> 18487851

Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis.

Angela R Kamer1, Ananda P Dasanayake, Ronald G Craig, Lidia Glodzik-Sobanska, Miroslow Bry, Mony J de Leon.   

Abstract

Alzheimer's disease (AD) affects approximately 4.5 million people in the U.S. and this number will increase as the population ages and the life-span increases. Therefore, of paramount importance is identifying mechanisms and factors that affect the risk of developing AD. The etiology and pathogenic mechanisms for AD have not been defined, although inflammation within the brain is thought to play a role. Consistent with this hypothesis, studies suggest that peripheral infections contribute to the inflammatory state of the central nervous system. Periodontitis is a prevalent, persistent peripheral infection associated with gram negative, anaerobic bacteria that are capable of exhibiting localized and systemic infections in the host. This review offers a hypothetical link between periodontitis and AD and will present possible mechanistic links between periodontitis related inflammation and AD. It will review the pathogenesis of periodontitis and the mechanisms by which periodontal infections may affect the onset and progression of AD. Since periodontitis is a treatable condition, it may be a readily modifiable risk factor for AD.

Entities:  

Mesh:

Year:  2008        PMID: 18487851     DOI: 10.3233/jad-2008-13408

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  40 in total

Review 1.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

3.  Immune and behavioral consequences of microglial reactivity in the aged brain.

Authors:  Angela M Wynne; Christopher J Henry; Jonathan P Godbout
Journal:  Integr Comp Biol       Date:  2009-04-23       Impact factor: 3.326

4.  Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.

Authors:  Supriti Samantaray; Varduhi H Knaryan; Donald C Shields; April A Cox; Azizul Haque; Naren L Banik
Journal:  Mol Neurobiol       Date:  2015-06-25       Impact factor: 5.590

Review 5.  Microglia in neurodegenerative disease.

Authors:  V Hugh Perry; James A R Nicoll; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

6.  Periodontal disease associates with higher brain amyloid load in normal elderly.

Authors:  Angela R Kamer; Elizabeth Pirraglia; Wai Tsui; Henry Rusinek; Shankar Vallabhajosula; Lisa Mosconi; Li Yi; Pauline McHugh; Ronald G Craig; Spencer Svetcov; Ross Linker; Chen Shi; Lidia Glodzik; Schantel Williams; Patricia Corby; Deepak Saxena; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2014-11-05       Impact factor: 4.673

Review 7.  Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  Clive Holmes; Darren Cotterell
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 8.  Gingipains from Porphyromonas gingivalis - Complex domain structures confer diverse functions.

Authors:  N Li; C A Collyer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 9.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.

Authors:  Angela R Kamer; Ronald G Craig; Elizabeth Pirraglia; Ananda P Dasanayake; Robert G Norman; Robert J Boylan; Andrea Nehorayoff; Lidia Glodzik; Miroslaw Brys; Mony J de Leon
Journal:  J Neuroimmunol       Date:  2009-09-19       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.